Cargando…

Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"

Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chalkidou, Kalipso, Li, Ryan, Culyer, Anthony J., Glassman, Amanda, Hofman, Karen J., Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384986/ https://www.ncbi.nlm.nih.gov/pubmed/28812807 http://dx.doi.org/10.15171/ijhpm.2016.118

Ejemplares similares

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

Priority-setting for achieving universal health coverage
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
por: Culyer, Anthony, et al.
Publicado: (2018)

Evidence-Informed Deliberative Processes for Universal Health Coverage: Broadening the Scope: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Gopinathan, Unni, et al.
Publicado: (2016)

Charging for the use of survey instruments on population health: the case of quality-adjusted life years
por: Teerawattananon, Yot, et al.
Publicado: (2020)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

Use of Evidence-Informed Deliberative Processes – Learning by Doing: Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Culyer, Anthony J.
Publicado: (2019)

Evidence-informed capacity building for setting health priorities in low- and middle-income countries: A framework and recommendations for further research
por: Li, Ryan, et al.
Publicado: (2017)

Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness
por: Baltussen, Rob, et al.
Publicado: (2016)

Priority Setting for Universal Health Coverage: We Need to Focus Both on Substance and on Process: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, not Just More Evidence on Cost-Effectiveness"
por: Lauer, Jeremy A., et al.
Publicado: (2017)

Economic Evaluation for Health Investments En Route to Universal Health Coverage: Cost-Benefit Analysis or Cost-Effectiveness Analysis?
por: Culyer, Anthony J., et al.
Publicado: (2019)

What is the value of explicit priority setting for health interventions? A simulation study
por: Barlow, Euan, et al.
Publicado: (2022)

Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK
por: Culyer, Anthony J., et al.
Publicado: (2021)

Don’t Discount Societal Value in Cost-Effectiveness: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Hall, William
Publicado: (2017)

Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making
por: Teerawattananon, Yot, et al.
Publicado: (2021)

Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia
por: Sharma, Manushi, et al.
Publicado: (2020)

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE
por: Tantivess, Sripen, et al.
Publicado: (2017)

Reinforcing Science and Policy, With Suggestions for Future Research: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Culyer, Anthony J.
Publicado: (2022)

Budgeting for a billion: applying health technology assessment (HTA) for universal health coverage in India
por: Dabak, Saudamini Vishwanath, et al.
Publicado: (2018)

We need a NICE for global development spending
por: Chalkidou, Kalipso, et al.
Publicado: (2017)

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations
por: Turner, Hugo C., et al.
Publicado: (2021)

Building Capacity for Evidence-Informed Priority Setting in the Indian Health System: An International Collaborative Experience()
por: Downey, L.E., et al.
Publicado: (2020)

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020)

How Should Global Fund Use Value-for-Money Information to Sustain its Investments in Graduating Countries?
por: Kanpirom, Kitti, et al.
Publicado: (2017)

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
por: Oortwijn, Wija, et al.
Publicado: (2022)

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
por: Oortwijn, Wija, et al.
Publicado: (2022)

How can we make better health decisions: a Best Buy for all?: Commentary based on discussions at iDSI roundtable on 2 (nd) May 2019 London, UK
por: O'Brien, Niki, et al.
Publicado: (2020)

Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Gopinathan, Unni
Publicado: (2023)

Institutionalisation Is a Vital Element for Fairness of Priority Setting in the Package Design if the Target is Universal Health Coverage: Comment on "Evidence-Informed Deliberative Processes for Health Benefits Package Design – Part II: A Practical Guide"
por: Sajadi, Haniye Sadat, et al.
Publicado: (2022)

Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: DiStefano, Michael J.
Publicado: (2022)

Deliberative engagement methods on health care priority-setting in a rural South African community
por: Tugendhaft, Aviva, et al.
Publicado: (2021)

Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact
por: Millar, Robyn, et al.
Publicado: (2021)

Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Bond, Kenneth
Publicado: (2022)

Value-based tiered pricing for universal health coverage: an idea worth revisiting
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation
por: Wang, Yi, et al.
Publicado: (2021)

Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Guzman, Javier
Publicado: (2022)

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
por: Butani, Dimple, et al.
Publicado: (2023)

Health and science: evidence, policy and advocacy
por: Durham, Justin
Publicado: (2022)

Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Goetghebeur, Mireille, et al.
Publicado: (2020)

Medical training for universal health coverage: a review of Cuba–South Africa collaboration
por: Squires, Neil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tml9juo69qsp1q1uj51guvmsis